Literature DB >> 1814578

Fibronectin immunoreactivity in neural trauma.

R A Egan1, V K Vijayan.   

Abstract

The presence of extracellular matrix protein fibronectin (FN) at the site of neural trauma was examined using immunohistochemical methods. At 2, 4 and 7 days following a penetrating wound through the rat cerebral cortex, FN staining was detected in the neuropil and in non-neuronal cells adjacent to the wound. FN-stained cells were GFAP-negative and were identified as brain macrophages based on cell surface staining for CR3 complement receptor. Our findings suggest a role for FN in the repair of neural trauma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1814578     DOI: 10.1016/0006-8993(91)91421-v

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Expression of alpha5 integrin rescues fibronectin responsiveness in NT2N CNS neuronal cells.

Authors:  Marit N Meland; Mary E Herndon; Christopher S Stipp
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

2.  The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism.

Authors:  Fenghua Hu; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-01-30       Impact factor: 6.167

Review 3.  Extracellular matrix and traumatic brain injury.

Authors:  Naijil George; Herbert M Geller
Journal:  J Neurosci Res       Date:  2018-01-18       Impact factor: 4.164

4.  Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy.

Authors:  D Biasoli; M F Sobrinho; A C C da Fonseca; D G de Matos; L Romão; R de Moraes Maciel; S K Rehen; V Moura-Neto; H L Borges; F R S Lima
Journal:  Oncogenesis       Date:  2014-10-20       Impact factor: 7.485

Review 5.  Integrins promote axonal regeneration after injury of the nervous system.

Authors:  Bart Nieuwenhuis; Barbara Haenzi; Melissa R Andrews; Joost Verhaagen; James W Fawcett
Journal:  Biol Rev Camb Philos Soc       Date:  2018-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.